M&T Bank’s Jazz Pharmaceuticals JAZZ Stock Holding History
Bought
Maintained
Sold
Other funds holding JAZZ
M&T Bank's JAZZ Position: Q2 2026 in Review
M&T Bank reduced its Jazz Pharmaceuticals (JAZZ) stake by 19% in Q2 2026, selling an estimated $86.1K and leaving 1,688 shares worth $406K. The position accounts for ﹤0.01% of the portfolio, ranked #1305.
M&T Bank first reported a position in JAZZ in Q1 2014 and has held it in 43 quarters since. The position peaked at $3.93M in Q1 2015. 647 funds tracked by Wall St. Rank hold JAZZ as of Q2 2026.
- M&T Bank held 1,688 shares of Jazz Pharmaceuticals worth $406K as of Q2 2026.
- M&T Bank sold 393 Jazz Pharmaceuticals shares in Q2 2026, an estimated $86.1K.
- Jazz Pharmaceuticals made up ﹤0.01% of M&T Bank's portfolio in Q2 2026, its #1305 holding.
- M&T Bank first reported a position in Jazz Pharmaceuticals in Q1 2014 and has held it in 43 quarters since.
- M&T Bank's Jazz Pharmaceuticals position peaked at $3.93M in Q1 2015.
- 647 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q2 2026.
Based on M&T Bank's 13F filing for Q2 2026, filed 4 Aug 2026.